Amisha Fnu
Researcher
Also affiliated: Central Arkansas Veterans Healthcare System (2021–2022); Winthrop Rockefeller Foundation (2022)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Amisha Fnu's research focuses on hematological malignancies, particularly multiple myeloma. Her work investigates treatment strategies for patients with persistent minimal residual disease after initial therapy. This includes studying the efficacy of tandem autologous stem cell transplantation as a subsequent treatment option.
Fnu has collaborated with researchers at the University of Arkansas for Medical Sciences, including Manojna Konda, Anusha Jillella, Nishanth Thalambedu, and Sravani Gundarlapalli, on multiple publications. Her scholarly output includes five publications, with a recent publication in 2022, indicating ongoing activity in her field. Her h-index is 1, with a total of 6 citations across her publications.
Metrics
- h-index: 1
- Publications: 5
- Citations: 6
Selected Publications
-
Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075] (2022)
-
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma (2022)
-
WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants? (2021)
-
How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants? (2021)
Collaboration Network
Top Collaborators
- How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
- WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants?
- Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075]
- How to treat left ventricular thrombi- warfarin or direct oral anti-coagulants?
- WITHDRAWN: How to treat left ventricular thrombi - Warfarin or direct oral anti-coagulants?
- Erratum to “How to treat left ventricular thrombi- Warfarin or direct oral anti-coagulants?” [Am. Heart J. Plus Cardiol. Res. Pract. 13 (January 2022) 100075]
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
- Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma
Similar Researchers
Based on overlapping research topics